KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Treasury Shares (2018 - 2025)

Cardlytics (CDLX) has disclosed Treasury Shares for 8 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 72.75% year-over-year to $7.8 million, compared with a TTM value of $7.8 million through Dec 2025, up 72.75%, and an annual FY2025 reading of $7.8 million, up 72.75% over the prior year.
  • Treasury Shares was $7.8 million for Q4 2025 at Cardlytics, down from $8.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $8.0 million in Q3 2025 and bottomed at $6666.0 in Q3 2021.
  • Average Treasury Shares over 5 years is $4.1 million, with a median of $4.9 million recorded in 2022.
  • The sharpest move saw Treasury Shares plummeted 99.47% in 2021, then surged 76212.63% in 2022.
  • Year by year, Treasury Shares stood at $2.3 million in 2021, then skyrocketed by 159.63% to $6.0 million in 2022, then dropped by 7.91% to $5.5 million in 2023, then fell by 17.83% to $4.5 million in 2024, then soared by 72.75% to $7.8 million in 2025.
  • Business Quant data shows Treasury Shares for CDLX at $7.8 million in Q4 2025, $8.0 million in Q3 2025, and $7.3 million in Q2 2025.